Table 1. Baseline clinical characteristics of the study patients.
| Total (N = 462) | |
| Age | 67.00 (58.00–72.00) |
| Male sex | 325 (70.3%) |
| BMI (kg/m2) | 25.29 (23.41–27.42) |
| Diabetes mellitus | 142 (30.7%) |
| On insulin therapy | 28 (6.1%) |
| Hypertension | 280 (60.6%) |
| Smoking history | 217 (47.0%) |
| Previous PCI | 83 (18.0%) |
| Previous CVA | 6 (1.3%) |
| CAD presentation | |
| SA | 371 (80.3%) |
| UA | 55 (11.9%) |
| NSTEMI | 19 (4.1%) |
| STEMI | 17 (3.7%) |
| Baseline laboratory findings | |
| Hematocrit (%) | 39.56±4.59 |
| Platelet count (102/mm3) | 205.00 (174.00–240.00) |
| Creatinine (mg/dL) | 0.83 (0.72–0.99) |
| HbA1c (%) | 6.10 (5.70–6.90) |
| TC (mg/dL) | 158.00 (135.75–183.00) |
| TG (mg/dL) | 122.00 (88.75–170.50) |
| HDL (mg/dL) | 41.00 (35.75–48.00) |
| LDL (mg/dL) | 89.00 (69.00–112.00) |
| Platelet function tests | |
| VerifyNow P2Y12 (PRU) | 232.00 (160.00–293.00) |
| MEA ADP (units) | 21.00 (15.00–31.00) |
BMI: body mass index; PCI: percutaneous coronary intervention; CVA: cerebrovascular accident; CAD: coronary artery disease; SA: stable angina; UA: unstable angina; NSTEMI: non-ST elevation myocardial infarction; STEMI: ST elevation myocardial infarction; TC: total cholesterol; TG: triglyceride; HDL: high-density lipoprotein; LDL: low-density lipoprotein; PRU: P2Y12 reaction units; MEA ADP: multiple electrode platelet aggregometry adenosine diphosphate test.